ProfileGDS5822 / ILMN_2514220
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 7% 8% 19% 24% 1% 17% 35% 1% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 18.67
GSM1276600PDAC Late Ablation Control 211.38
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 111.219
GSM1276603PDAC Late Ablation 213.124
GSM1276604PDAC Late Ablation 31.41
GSM1303940PDAC Late Ablation_anti-CTLA4 11217
GSM1303941PDAC Late Ablation_anti-CTLA4 216.935
GSM1303942PDAC Late Ablation_anti-CTLA4 31.21